Gemma Biotherapeutics ("GEMMABio"), a clinical‑stage, global, genetic medicines company, today announced the presentation of preclinical data supporting candidate declaration for GB703, a novel, ...
The Independent on MSN
Five early signs of SMA every parent should look out for
What is SMA? Key signs to look out for in babies as Jesy Nelson highlights life-changing condition - Pop star Jesy Nelson has ...
Medicines watchdog approves two treatments for patients with spinal muscular atrophy ...
Key signs of spinal muscular atrophy include severe muscle weakness, difficulty breathing or swallowing, and missing ...
MEDICINES for babies with spinal muscular atrophy will be funded by the NHS for all patients for the first time. Little Mix ...
The decision marks a significant milestone after both medicines were previously made available through managed access agreements while additional evidence on their effectiveness was gathered. SMA is a ...
Regenxbio is pitching at FDA approval next year for its Duchenne muscular dystrophy (DMD) gene therapy RGX-202, after ...
Treatment for a rare muscle-wasting condition for a nine-year-old has "fundamentally changed the course of his life", his ...
Spinal muscular atrophy is a rare, genetic condition that causes progressive muscle weakness and loss of movement, and can ...
The family of a three-year-old girl with a rare muscle disease are facing a bill of £7,000 for adaptations to their home.
Spinal muscular atrophy (SMA) is a genetic, progressive neuromuscular disorder. SMA affects muscle-controlling nerve cells, called motor neurons, in the spinal cord. The condition leads to muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results